TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell cancer (RCC) in patients that are medically inoperable or at high-risk of post-surgical dialysis. The objective of the FASTRACK II clinical trial is to investigate the ef...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Cancer
Main Authors: Siva, Shankar, Chesson, Brent, Bressel, Mathias, Pryor, David, Higgs, Braden, Reynolds, Hayley M., Hardcastle, Nicholas, Montgomery, Rebecca, Vanneste, Ben, Khoo, Vincent, Ruben, Jeremy, Lau, Eddie, Hofman, Michael S., De Abreu Lourenco, Richard, Sridharan, Swetha, Brook, Nicholas R., Martin, Jarad, Lawrentschuk, Nathan, Kron, Tomas, Foroudi, Farshad
格式: Artigo
語言:Inglês
出版: BioMed Central 2018
主題:
Study Protocol
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199711/
https://ncbi.nlm.nih.gov/pubmed/30352550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4916-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍